28th April 2025
28th April 2025
The DaaP buyer is one of the world’s largest and most respected healthcare companies. Founded in the United States, it operates globally across three major sectors: pharmaceuticals, medical, and consumer health, and has proudly increased its dividend every year for the past 63 years.
Their formal announcement is subject to final corporate approval. The DaaP buyer has advised that the announcement will be published in the medtech section of their website on Friday, 2nd May 2025.
While there have been some unavoidable setbacks, we want to reassure shareholders that everything is advancing and that we are now at the finish line.
The Company fully understands and shares shareholders’ frustration and anxiety during this period. We are grateful for your continued patience and support as we move towards completion.
Licence notifications are currently being processed and will be distributed this week, as previously communicated.
The Company remains bound by strict non-disclosure agreements.
All official information will be published exclusively at www.cloudtag.com.